Search Results 1631-1640 of 16084 for aloe vera benefits

1. A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

2. A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

3. A Study to Evaluate Trifluridine/Tipiracil Combined with Bevacizumab vs Trifluridine/Tipiracil to Treat Patients with Refractory Metastatic Colorectal Cancer - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

4. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

5. A Study to Evaluate Trifluridine/Tipiracil in Combination with Irinotecan to Treat Biliary Tract Cancers - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

6. Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

7. A Study of the Effect of Ileal Bile Acid Transporter Inhibitor for Functional Constipation - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

8. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

9. Safety Study of VAL-083 in Patients with Recurrent Malignant Glioma - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

10. Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...